Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients

CYP2B6 Polymorphisms Influence the Plasma Concentration and Clearance of the Methadone S-Enantiomer

(2011) Sheng-Chang Wang et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Stereo-Selective Metabolism of Methadone by Human Liver Microsomes and cDNA-Expressed Cytochrome P450s: A Reconciliation

(2010) Yan Chang et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response

(2010) Ming-Hsien Tsai et al.   PHARMACOGENOMICS

Drug Treatment as HIV Prevention: Expanding Treatment Options

(2010) David S. Metzger et al.   Current HIV/AIDS Reports

Role of CYP2B6 in Stereoselective Human Methadone Metabolism

(2009) Rheem A. Totah et al.   ANESTHESIOLOGY

Development of a method to measure methadone enantiomers and its metabolites without enantiomer standard compounds for the plasma of methadone maintenance patients

(2009) Sheng-Chang Wang et al.   BIOMEDICAL CHROMATOGRAPHY

Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity

(2009) Evan D. Kharasch et al.   DRUG AND ALCOHOL DEPENDENCE

Development of the treatment outcomes profile

(2008) John Marsden et al.   ADDICTION

Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients

(2008) Xiao-yan Qiu et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Selecting an Appropriate Medication for Treating Neuropathic Pain in Patients with Diabetes: A Study Using the U.K. and Germany Mediplus Databases

(2008) Mugdha Gore et al.   Pain Practice

Actual and Potential Drug Interactions Associated with Methadone

(2007) Douglas J. Weschules et al.   PAIN MEDICINE